Correlation Between Denali Therapeutics and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Indaptus Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Indaptus Therapeutics.
Diversification Opportunities for Denali Therapeutics and Indaptus Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Denali and Indaptus is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Indaptus Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 1.32 times less return on investment than Indaptus Therapeutics. But when comparing it to its historical volatility, Denali Therapeutics is 1.4 times less risky than Indaptus Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 171.00 in Indaptus Therapeutics on November 2, 2024 and sell it today you would lose (76.00) from holding Indaptus Therapeutics or give up 44.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Denali Therapeutics vs. Indaptus Therapeutics
Performance |
| Timeline |
| Denali Therapeutics |
| Indaptus Therapeutics |
Denali Therapeutics and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Indaptus Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |